What this study is
This is a prospective randomized controlled trial with the purpose to determine if patients undergoing fibular collateral ligament (FCL) reconstruction alone or combined FCL and anterior cruciate ligament (ACL) reconstructions can safely begin full controlled weightbearing for the first six weeks after surgery.
What's being tested
- Physical Therapy
Intervention · OTHER
Patient is randomized to the weightbearing group the day after surgery.
Study details
- Official title
- Full Weightbearing Versus Partial Controlled Weightbearing During the First Six Weeks of Rehabilitation After Reconstruction of the Fibular Collateral Ligament: A Randomized Controlled Trial
- Sponsor
- Twin Cities Orthopedics
- Conditions
- Knee Injuries
- Enrolling
- 50 people
- Starts
- 2020-01-01
- Est. completion
- 2027-12
- Design
- Single-blind, randomized, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 14 Years – 59 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- ≥ 14 years old, <60
- Reconstruction of FCL alone
- Combined FCL + ACL reconstructions
- Males or females
- Is willing and able to comply with the clinical trial plan and able to understand and sign the Patient Informed Consent Form.
You can't join if
- < 14 years old, > 60
- Pregnant
- Revision FCL reconstructions
- Concurrent biceps femoris or lateral capsular repairs
- Concurrent PCL or MCL reconstructions
- Concomitant meniscus root or radial repair surgery with transtibial technique
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openTwin Cities Orthopedics
Edina, Minnesota, United States
- Becky Stone · Contact952-456-7136research@tcomn.com
- Robert F LaPrade, MD, PhD · Principal investigator
Recruiting
Study team
Sponsor
Twin Cities Orthopedics
Study ID RFL_FWB vs PWB-FCL
Principal investigator
Robert F LaPrade, MD, PhD
Twin Cities Orthopedics
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.